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The histologic diagnosis of active myocarditis is frequently 
difficult to establish. A nonhistologic marker of immune 
activation would be clinically useful in identifying cases of 
immune-mediated myocarditis. A viral etiology with subse- 
quent autoimmunity to cardiac antigens has been impli- 
cated in human myocarditis. Because autoimmunity and 
viral disease are commonly associated with increased 
expression of major histocompatibility complex (MHC) 
antigens on targeted tissue, we examined endomyocardial 
biopsy samples from patients with active myocarditis for 
abnormal levels of MHC antigen expression. Thirteen 
patients with active myocarditis and eight control patients 
with other well-defined cardiac diagnoses (coronary dis- 
ease, amyloidosis or neoplasm) were studied. 
A sensitive radioimmunoassay was developed that uti- 
lized monoclonal antibodies to human MHC class I and 
Experience with the role of endomyocardial biopsy in pa- 
tients with suspected myocarditis has resulted in the devel- 
opment of a reproducible histologic definition of active 
myocarditis (1). The finding of both myocardial inflammation 
and myocyte necrosis establishes the diagnosis of active 
myocarditis. Although the diagnosis can be made reproduc- 
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class II antigens in order to quantitate the expression of 
both of these antigens within each biopsy. Abnormal MHC 
class I and class II antigen expression was present in 11 of 
13 myocarditis specimens and 1 of 8 control samples 
(specificity 88%) sensitivity 84.6%). Active myocarditis 
samples had approximately a lo-fold increase in MHC class 
I and class II expression. Immunoperoxidase staining local- 
ized abnormal MHC expression primarily within microvas- 
cular endothelium and along myocyte surfaces (11 of 13). 
This study is the first to demonstrate a marked increase 
in major histocompatibility complex antigen expression 
within the myocardium of patients with active myocarditis. 
The identification of abnormal histocompatibility antigen 
expression within an endomyocardial biopsy may prove a 
useful adjunct to the histologic diagnosis of myocarditis. 
(J Am Co11 CardiolI990;15:624-32) 
ibly by expert cardiac pathologists, certain histologic fea- 
tures of human myocarditis may make the diagnosis difficult 
to establish in all cases. The inflammatory cell infiltrates are 
frequently focal and, in all but the most severe cases of 
myocarditis, foci of myocyte necrosis may be difficult to 
locate. Nonhistologic markers within the myocardium that 
would be uniformly expressed throughout the tissue sample 
would be clinically useful as an adjunct to the histologic 
diagnosis. 
Chagasic (2) and rheumatic myocarditis (3) are both 
clearly associated with infectious agents, and recent identi- 
fication of enteroviral RNA within endomyocardial biopsy 
samples of idiopathic myocarditis supports the hypothesis 
that many cases of myocarditis may be initiated by a viral 
infection (4). This hypothesis has broad support in both 
clinical and experimental studies (5-16) and, although the 
precise role of virus or viruses in myocarditis is not yet fully 
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defined, postviral autoimmunity to cardiac-specific antigens 
has been described in both animal models and human 
myocarditis. 
Major histocompatibility complex (MHC) molecules play 
an important role in presenting antigens such as a virus to the 
immune system. T lymphocytes thus recognize these anti- 
gens only in the context of self-MHC molecules, a phenom- 
enon known as MHC-restriction (17,18). MHC class I mol- 
ecules are present to some extent on virtually all nucleated 
cells (18,19) and, in association with viral antigens, appear to 
be the target of sensitized, predominantly CD8+ cytotoxic T 
cells. MHC class II molecules, on the other hand, are 
expressed primarily on antigen presenting cells of the im- 
mune system such as macrophages and B cells and in the 
presence of processed antigen predominantly activated 
CD4+ (helper) T cells (20). Increased expression of these 
MHC antigens has been demonstrated in human tissues 
undergoing autoimmune injury (20-22), allograft rejection 
(23-26), viral diseases and other inflammatory states (27-29). 
Normal human fetal and adult cardiac myocytes express low 
levels of MHC class I (HLA, A, B and C regions) antigens 
and do not express detectable levels of MHC class II (HLA 
DP, DQ and DR regions) antigens (19,20,30,31). 
We used monoclonal antibodies directed against mono- 
morphic determinants of human MHC class I and class II 
antigens to examine endomyocardial biopsy specimens from 
selected patients with idiopathic myocarditis to determine 
whether altered expression of MHC antigens could be de- 
tected within the myocardium. The control group comprised 
patients with no histologic evidence of myocarditis on endo- 
myocardial biopsy who were later found to have clear-cut 
clinical and histopathologic diagnoses explaining their left 
ventricular dysfunction. 
Methods 
Study patients. Between June 1986 and April 1987, 80 
patients with clinically suspected myocarditis underwent 
endomyocardial biopsy. All patients had some degree of left 
ventricular dysfunction after an initial presentation of rapid 
onset congestive heart failure and inadequate clinical re- 
sponse to conventional therapy with diuretics, digoxin and, 
frequently, vasodilators. All patients underwent initial eval- 
uation including history, physical examination, routine he- 
mograms and serum chemistry determinations, screening for 
collagen-vascular disease, thyroid function testing and 
screening for pheochromocytoma. All patients then gave 
informed consent and underwent endomyocardial biopsy 
and right heart catheterization. At the time of catheteriza- 
tion, serum was obtained for identification of heart autoanti- 
bodies. Written informed consent for this protocol was also 
obtained. 
Endomyocardial biopsy. Biopsy was performed by way 
of the right internal jugular vein with a modified Caves 
Figure 1. Photomicrograph of an endomyocardial biopsy sample 
from a patient with active myocarditis, showing the focal interstitial 
collection of inflammatory cells surrounding a necrotic myocyte 
(arrows) (hematoxylin-eosin stains; x350). 
bioptome. During the procedure a minimum of three sepa- 
rate endomyocardial biopsy specimens were obtained for 
routine histologic examination and one specimen was frozen 
for immunohistochemistry studies. 
Histology. All biopsy specimens were serially sectioned 
and examined with use of hematoxylin-eosin staining. Five 
serial sections of 5 pm thickness were cut and placed on 
each of seven glass slides so that the majority of the biopsy 
tissue was examined. Each set of biopsy specimens was 
examined by two cardiac pathologists who were unaware of 
patient data. Myocarditis was defined according to the 
Dallas criteria as inflammation of the myocardium associated 
with necrosis and degeneration of adjacent myocytes not 
typical of the ischemic damage seen with coronary artery 
disease (1) (Fig. 1). 
Semiquantitation of major histocompatibility complex class 
I and class II expression. Endomyocardial biopsy sections 
were assessed for relative levels of MHC class I and class II 
expression using standard immunoperoxidase techniques. 
Frozen sections were treated with either monoclonal antihu- 
man class 1 (clone W6132, ATCC), antihuman class II (clone 
L-243, ATCC) or normal mouse serum, and incubated with 
biotin-conjugated rabbit antimouse immunoglobulin (Ig) and 
an avidin-biotinylated horseradish peroxidase complex (Vec- 
tor Labs). After washing, sections were incubated with a 
peroxidase substrate, amino ethylcarbazole (AEC), washed 
and mounted. 
Triplicate slides were coded and the relutive reactivity 
wus scored semiquantitatively by two independent observ- 
ers. With each experimental run, tissues from an autopsy, 
normal control case and a case of fatal coxsackie B, virus 
culture, positive myocarditis were included. The biopsies 
were scored for levels of MHC antigen expression on capil- 
lary, venous and arteriolar endothelium as well as for MHC 
expression on myocytes. The final results represent the 
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consensus of the two individuals who scored the entire panel assay. Data are expressed as raw counts/min or as the ratio 
of slides. Immunoperoxidase staining was scored as follows: of class I or class II activity to myosin activity. 
0 to lt = weak, focal staining similar to that seen in 
negative control samples; myocytes are negative, endothe- 
lial cells lining the vessels usually contributing to the weak 
staining. 
2t = endothelial cells more positive; myocyte sarcolem- 
ma1 surfaces are negative. 
3t = endothelial cells lining both venous and arteriolar 
beds are strongly positive; myocyte surfaces are focally 
positive, whereas cytoplasmic structures and intercalated 
discs have a weak, diffuse staining. 
4t = intense diffuse staining of endothelial cells and 
multifocal myocyte sarcolemmal staining. 
Quantitation of MHC class I and class II expression. The 
radioimmunoassay was performed by removing the OCT 
compound from each biopsy specimen and cutting 5 pm 
sections. Four sections were transferred to glass tubes 
previously coated overnight with 5% bovine serum albumin, 
and each assay was performed in triplicate. Each tube 
contained 3 ml of medium (RPM1 1640 supplemented with 
100 pg/ml streptomycin, 100 U/ml penicillin, 2 mM L- 
glutamine and 5% heat-inactivated fetal calf serum) contain- 
ing 0.1 M phenyl methyl sulphonyl fluoride (Sigma Chemi- 
cal). After incubation at 4°C for 20 min, tubes were 
centrifuged at 650 g, the fluid was drained and 3 ml of RPM1 
medium containing 5% normal mouse serum was added. 
After incubation at 4°C for 20 min, to each set of triplicate 
tubes was added either normal mouse serum (control), 
antihuman cardiac myosin (EU-lHl), antihuman monomor- 
phic MHC class I (W6/32) or antihuman monomorphic MHC 
class II (L-243). The tubes were vortexed, incubated for 60 
min at 4°C and washed twice with phosphate-buffered saline 
solution pH 7.4. To each tube, RPM1 medium containing 5% 
normal goat serum was added (3 ml/tube) and following 
incubation at 4°C for 20 min the fluid was drained and affinity 
purified Iodine-125-labeled goat antimouse immunoglobulin 
(100 ~1, 1:50 containing 50,000 countslmin) was added. After 
gentle mixing and incubation for 30 min at 4°C the tubes 
were washed three times with phosphate-buffered saline 
solution and then counted in an LKB gamma counter. 
Autopsy tissue sections from a normal human heart (from a 
case involving trauma) and tissue sections from the heart of 
a patient who died of acute myocarditis were run in parallel 
and served as negative and positive controls, respectively. 
Mean values t SD in countslmin for the triplicate samples 
were calculated. Any assay giving less than a fivefold 
increase in activity between the negative and positive con- 
trol was rejected and, hence, repeated. 
Indirect immunofluorescence. Standard techniques for in- 
direct immunofluorescence were used (32). Heart, kidney, 
liver, skeletal muscle and stomach were removed from 6 
month old Sprague-Dawley rats (Charles River) and frozen 
and 4 pm sections were cut in a cryotome. The sections were 
overlaid with human serum diluted l:lO, 1:20, 1:40 and 180 
and incubated with goat antihuman Immunoglobulin G, 
crystallization fraction (Fc) gamma chain specific (Organon 
1202-0121, lot # 27107), 50 ~1 FITC at 1:40 dilution. A 
rhodamine counterstain was used at 20 pi/ml (Difco Labo- 
ratories). The slides were rinsed and washed for 30 min in 
phosphate-buffered saline solution. The sections were 
mounted with 90% (vol/vol) glycerol/phosphate-buffered sa- 
line solution and examined using a Zeiss fluorescent micro- 
scope. 
Statistical analysis. Comparisons between the two patient 
groups were made with use of the Student’s t test. Propor- 
tions were analyzed using the chi-square test. Linear and 
logistic regression analyses were used to determine the 
relations among clinical, serologic and immunohistochemi- 
cal data. Differences achieved statistical significance when 
two-tailed p values were ~0.05. Group means are expressed 
as mean values ? SD, unless otherwise noted. 
Results 
Endomyocardial biopsies. All 80 endomyocardial biopsy 
specimens contained at least three separate endomyocardial 
fragments for routine examination by hematoxylin-eosin 
staining (mean 5.7 fragments). Thirteen (16%) of the 80 
patients had biopsy specimens that fulfilled the histologic 
criteria for active myocarditis (Fig. 1). In addition, 8 patients 
(10%) had no evidence of myocarditis, but other clear-cut 
clinical or histopathologic diagnoses were established (dis- 
cussed later). These eight patients constitute the control 
group. The remaining 59 patients (73.5%) who are not re- 
ported on in this study had either normal appearing biopsy 
specimens or specimens showing various degrees of myocyte 
hypertrophy and interstitial fibrosis, consistent with the diag- 
nosis of idiopathic cardiomyopathy or borderline myocarditis. 
To adjust for differences in the size of each biopsy sample 
used in the radioimmunoassay, a monoclonal anticardiac 
myosin reagent was used. Cardiac myosin is the major 
intracellular protein within the myocardium and, therefore, 
reflects the quantity of tissue examined in the radioimmuno- 
Clinical data (Table 1). A description ofthe patient’s age, 
sex, clinical diagnosis, New York Heart Association func- 
tional class and ejection fraction is given in Table 1. The 
patients with myocarditis were younger than the control 
group without myocarditis (38.7 ? 14.2 versus 53.4 2 15.1 
years, p = 0.035). There were no significant differences 
between the two groups with respect to gender, functional 
class or ejection fraction. Of the 13 patients with myocardi- 
tis, 3 had postpartum myocarditis (Patients 6, 11 and 12), 
whereas the remaining 10 had idiopathic active myocarditis. 
Of the 8 control patients, 5 (Patients 14 to 18) were found to 
have severe coronary disease on subsequent left heart cath- 
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Table 1. Clinical Data on 13 Patients With and 8 Without 
Myocarditis. Comparison of Semiquantitative Scores for MHC 
Antigen Expression in Endomyocardial Biopsy Samples 
Using Immunoperoxidase 
Patient 
No. 
Age W 
Gender 
NYHA 
Class* 
Ejection 
Fraction 
(%) 
Relative Levels of 
MHC Antigen 
Expression by 
Immunoperoxidaset 
Class I Class II 
Myocarditis Group 
1 25/M 3 22 
2 54/F 3 18 
3 22lF 4 20 
4 27/M 2 36 
5 58/M 3 17 
6 38/F 4 23 
I 27/M 2 27 
8 53/F 3 29 
9 48/M 2 27 
10 28lF 3 30 
11 31/F 2 26 
12 30/F 3 20 
13 62/M 3 23 
Mean 38.7 2.9 24.2 
&SD 14.2 0.7 5.5 
2 
1 
4 
2.6 
1.0 
1 
0 
3 
0 
3 
2.3 
1.4 
Nonmyocarditis Group 
14 67/M 3 20 0 1 
15 42/M 3 23 1 0 
16 60/M 4 20 0 1 
17 49/M 3 19 I 0 
18 33/M 2 24 2 0 
19 75lM 3 20 1 2 
20 38iF 2 45 2 0 
21 63/F 2 40 2 0 
Mean 53.4 2.8 26.4 1.1 0.5 
+SD 15.1 0.7 10 0.8 0.8 
p Values 0.035 NS NS 0.002 0.002 
*New York Heart Association functional class. tsemiquantitative scoring 
from 0 to 4. F = female; M = male; MHC = major histocompatibility 
complex; NS = not signficant. 
eterization, 2 (Patients 19 and 21) were found to have 
significant amyloid infiltration of the myocardium by endo- 
myocardial biopsy and 1 patient (Patient 20) had a significant 
pericardial effusion secondary to metastatic esophageal car- 
cinoma. 
Immunohistochemistry. Normal cardiac tissue from con- 
trol autopsy samples did not show greater than grade 1 major 
histocompatibility complex (MHC) class I antigen expres- 
sion by the immunoperoxidase method. Myocytes appeared 
uniformly negative; however, within the interstitium there 
was a faint staining pattern in what appeared to be endothe- 
lial cells lining the microcirculation (Fig. 2). MHC class II 
antigen expression was essentially negative except for rare 
interstitial cells that were faintly positive. Although the 
Figure 2. Control autopsy specimen from a patient with no history 
of heart disease. Frozen section treated with monoclonal antihuman 
MHC class I antigen using standard immunoperoxidase technique; 
Faint staining of capillary endothelium scattered throughout the 
sample (arrows) (myocytes do not stain: x250). 
identity of these cells is not known, they likely represent 
interstitial dendritic cells. Positive autopsy control cases 
consisted of cases of culture-proved viral myocarditis in 
which the myocytes and microvascular endothelium ap- 
peared uniformly and intensely positive for both MHC class 
I and MHC class II antigens. Three of the eight patients in 
the nonmyocarditis control group (Patients 18, 20 and 21) 
had a grade 2 immunoperoxidase score for MHC class I 
antigen in consistent with increased expression of endothe- 
lial MHC class I antigen (specificity 63%) (Fig. 3). Only one 
of these eight control patients (Patient 19) had a grade 2 
score for MHC class II antigen expression (specificity 88%). 
None of the nonmyocarditic control samples had myocyte 
Figure 3. Endomyocardial biopsy frozen section sample from non- 
myocarditis control patient with grade 2 immunoperoxidase score 
for MHC class I antigen expression, with increased staining inten- 
sity of the microvascular endothelium compared with Figure 2 
(myocytes do not stain; x 160). 
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Table 2. Major Histocompatability Complex (MHC) Class I and 
Class II Antigen Expression as Determined by Radioimmunoassay 
With the Presence of Circulating Heart Autoantibodies (IFA) in 
Patients With and Without Myocarditis 
Patient 
No. Class I* Class II* Class It Class IIt Autoantibodies 
Myocarditis 
1 21,721 36,587 1.39 2.35 
2 18,016 28,057 0.87 1.37 
3 11,696 14,751 1.19 1.51 
4 15,775 21,981 1.25 1.74 
5 1,449 7,050 0.09 0.45 
6 25,483 33,671 2.02 2.67 
7 13,351 7,168 0.84 0.45 
8 11,700 6,398 0.69 0.38 
9 27,254 16,999 1.32 0.83 
10 1,280 482 0.09 0.03 
I1 8,331 12,298 0.41 0.61 
12 4,438 1,456 0.19 0.06 
13 31,276 25,782 1.60 1.32 
Mean 14,752 16,360 0.92 1.06 
*SD 9,710 12,007 0.61 0.85 
Yes (1:80) 
Yes (1:80) 
Yes (1:80) 
Yes (1:EO) 
Yes (1:40) 
Yes (1:20) 
No 
No 
No 
No 
No 
Yes (1:20) 
Yes (1:80) 
Nonmyocarditis 
14 2,022 680 0.16 0.05 No 
15 1,253 2,347 0.07 0.13 No 
16 1,231 3,898 0.08 0.24 No 
17 631 684 0.04 0.04 No 
18 635 171 0.04 0.01 No 
19 1,860 2,024 0.10 0.11 No 
20 739 1,748 0.03 0.07 NA 
21 1,077 757 0.06 0.04 NA 
Mean 1,181 1,833 0.070 0.087 
*SD 532 1,222 0.043 0.07 
p values 0.0003 0.003 0.001 0.005 
*raw counts/min. tratio of class I and class II countsimin to antimyosin 
countsimin. IFA = indirect immunofluorescene assay; NA = not available. 
MHC class I or class II antigen expression (specificity 
100%). 
The active myocarditis group revealed a sign&ant in- 
crease in expression of both MHC class I and class II 
antigens, by both semiquantitative and quantitative methods 
(Tables 1 and 2). The cardiac interstitium is frequently a 
compressed space and precise identification of peroxidase- 
positive stained interstitial cells would require immunoelec- 
tron microscopic technique not employed in this study. The 
morphologic appearance of the majority of the positive- 
stained cells is that of microvascular endothelial cells. The 
presence or absence of MHC antigen expression on Purkinje 
cells could not be determined with the standard immunoper- 
oxidase techniques used in this study. 
Microvascular endothelial and sarcolemmal staining. In- 
creased MHC class I microvascular endothelial staining 
(2 grade 2 by immunoperoxidase) was seen in 11 of 13 
myocarditis samples (sensitivity 84.6%), whereas MHC 
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class II endothelial staining was increased in 9 of 13 samples 
(sensitivity 69%). Eight of myocarditis samples had myocyte 
sarcolemmal staining for MHC class I (2 grade 3 by immu- 
noperoxidase) (sensitivity 62%). Similarly, 8 of the 13 sam- 
ples had sarcolemmal staining for MHC class II (sensitivity 
62%) (Table 1, Fig. 4). Only two active myocarditis samples 
did not have increased expression of either MHC class I or 
MHC class II on myocytes (Patients 10 and 12). Some cases 
with intense microvascular and sarcolemmal staining had a 
faint diffuse staining within myocyte cytoplasm. This pattern 
was considered an artifact, because we are not aware of any 
precedent for MHC expression within the cytoplasm of cells. 
Sensitivity and specificity. Radioimmunoassay results on 
MHC class I and II expression are expressed as the mean of 
three separate measurements. Standard deviations for these 
triplicate measurements did not differ from the raw count by 
more than 4% to 9%. Raw counts per patient biopsy are 
listed in Table 2. Data normalized for variations in biopsy 
size from patient to patient are expressed as a ratio of class 
I and class II to myosin content (Table 2, Fig. 5). For the 
radioimmunoassay, abnormal expression of MHC class Z 
and class ZZ antigens was dejined as any value above 2 SD 
above the mean of values from the nonmyocarditis control 
group (expressed as ratios of countslmin to cardiac myosin 
(class Z > 0.159, class ZZ > 0.235). With the use of these 
ratios in seven of eight control specimens (specificity 88%), 
values in each fell within the normal range for class I 
expression as well as class II expression (Table 2). In the 
myocarditis group, 2 of 13 samples (from Patients 5 and 10) 
fell within the designated normal range for MHC class I 
expression (sensitivity 84.6%), whereas 2 of 13 samples 
(from Patients 10 and 12) fell within the designated normal 
range for MHC class II expression. These patients could not 
be histologically or clinically distinguished from the other 
patients with myocarditis. 
Comparison of radioimmunoassay and immunoperoxidase 
techniques. Linear regression analysis revealed significant 
correlations between the radioimmunoassay technique both 
for quantitative MHC class I and class II expression and 
their respective semiquantitative immunoperoxidase scores 
(MHC class I: R = 0.911, R2 = 0.830, p < 0.001; MHC class 
II: R = 0.825, R2 = 0.681, p < 0.001). Multiple logistic 
regression analysis identified both the raw counts/min for 
MHC class I (p < 0.0005) and the ratio of class II to myosin 
content (p = 0.008) as independent and additive predictors of 
a positive biopsy for active myocarditis. The specificities, 
sensitivities and predictive values for various combinations 
of quantitative variables that distinguish myocarditis sam- 
ples are listed in Table 3. This logistic regression indicates 
that semiquantitative immunoperoxidase scores are not as 
significantly predictive of active myocarditis as the quanti- 
tative radioimmunoassay measurements. 
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Comparison between MHC class I and II expression within 
each group. Within the myocarditis group, both MHC class 
I and class II expressions were similarly increased (semi- 
quantitative immunoperoxidase: 2.6 + 1.0 and 2.3 t 1.4, 
respectively; quantitative radioimmunoassay: 0.92 2 0.61 
and 1.06 2 0.85, respectively). Similarly, no significant 
differences were present between MHC class I and class II 
expressions within the nonmyocarditis control group (semi- 
quantitative immunoperoxidase 1.1 t 0.8 versus 0.5 2 0.8; 
quantitative radioimmunoassay, 0.07 k 0.04 versus 0.09 2 
0.07, respectively). 
Circulating autoantibodies. Significant titers of heart 
autoantibodies (immunoglobulin G isotype) were identified 
in serum from 8 of 13 patients with myocarditis (prevalence 
61.5%) but were not present in any of the 6 control patients 
where serum was available for study. Immunoglobulin G 
(IgG) heart autoantibody titers of 220 are seen in only 4% of 
normal volunteer control subjects (unpublished data). Linear 
regression analysis revealed good correlation between both 
quantitative MHC class I expression and circulating Immu- 
noglobulin G heart autoantibody titer (r = 0.593, p = 0.006), 
and quantitative MHC class II expression and circulating 
Immunoglobulin G heart autoantibody titer (r = 0.708, p < 
0.001). Of the eight patients with myocarditis with significant 
Figure 4. Photomicrographs of biopsy samples from three patients 
with active myocarditis. a) Endomyocardial biopsy frozen section 
sample from a patient with active myocarditis with grade 3 immu- 
noperoxidase score for MHC class I antigen expression. The myo- 
cytes are cut tangentially in this section. Microvascular and venular 
endothelium intensely stained; focal sarcolemmal staining is also 
seen (arrows), which appears linear and intense and only involves 
discrete myocyte clusters within a biopsy specimen (x380). b) 
Photomicrograph showing grade 4 immunoperoxidase score for 
MHC class II antigen expression. The myocytes are cut longitudi- 
nally in this section. Intense staining of the microcirculation (small 
arrows) throughout the specimen, focal sarcolemmal staining (large 
arrows) and staining of the intercalated disc regions (X 380). c) 
Photomicrograph highlighting discrete myocyte sarcolemmal stain- 
ing. Frozen sample from a patient with active myocarditis, treated 
with monoclonal antibody to MHC class II antigen (x600). 
titers of circulating heart autoantibodies, seven had abnor- 
mal expression of MHC class II antigens by both the 
immunoperoxidase and the radioimmunoassay methods. 
Discussion 
This study provides the first evidence that human myo- 
carditis is associated with abnormal myocardial expression 
of class I and class II major histocompatibility complex 
(MHC) antigens. The data support the hypothesis that in 
many cases of active myocarditis, both myocytes and inter- 
stitial components such as microvascular endothelium are 
the specific targets of immune-activated inflammatory cells. 
Mechanisms: the role of the major histocompatibility com- 
plex in presenting cardiac antigen or antigens. The histologic 
hallmark of active myocarditis is the presence of inflamma- 
tory cells within the myocardium associated with focal 
myocyte necrosis. A leading hypothesis suggests that many 
cases of myocarditis are triggered by infection with a car- 
diotropic virus (5-16), which may be followed by a subacute 
or chronic immune response within the myocardium. Car- 
diac antigens could be liberated by the direct cytocidal effect 
on myocytes or as aberrantly expressed antigens on the 
surface of virally infected cells. This study demonstrates the 
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Figure 5. Radioimmunoassay results from individual patients for 
ratio of MHC class I and class II antigen expression to myosin 
expression, showing clusters of low ratios for the nonmyocarditis 
control samples. Top, MHC class I ratios; bottom, MHC class II 
ratios. Bars represent mean values k standard deviations. 
induction of MHC class I and class II antigens both within 
the cardiac interstitium and on myocytes, allowing cardiac 
antigen or antigens to be recognized by the immune system 
in the context of self-MHC molecules (17,lQ A chronic 
Table 3. Specificities, Sensitivities and Predictive Values of 
Various Combinations of the Significant Immunopathologic 
Variables That Distinguish Myocarditis Cases From 
Nonmyocarditis Control Cases 
Positive Negative 
Specificity Sensitivity Predictive Predictive 
(%I (%) Value (%) Value (%) 
A. Counts/min class I 100 86 100 80 
MHC* 
B. Ratio class II counts/min 88 79 92 70 
to antimyosin 
counts/mint 
C. Countslmin class I and 100 71 100 67 
ratio class II 
D. Countslmin class I or 88 93 93 88 
ratio class II 
*raw countsimin. tratio of class I and class II countslmin to antimyosin 
countslmin. MHC = major histocompatibility complex. 
state of inflammation characteristic of human myocarditis 
could thus be generated. 
The well characterized MHC class I (HLA A, B and C) 
antigens are found on virtually all nucleated cells. Dual 
recognition of MHC class I and class II antigens is necessary 
for activation by cytotoxic T cells for lysis of virus-infected 
cells (28) and cells bearing alloantigens (18). The MHC class 
II antigens are involved in communication among cells that 
regulate the immune response. These antigens are found 
primarily on B lymphocytes and on antigen-presenting cells, 
for example, Kupffer cells in the liver, Langerhans cells in 
the skin, interstitial dendritic cells in the heart (33). Low 
levels of MHC class II antigens may also be found on 
capillary endothelium. Normal fetal and adult myocytes 
express very low levels of MHC class I antigens and do not 
have detectable levels of MHC class II antigens (30). Endo- 
thelial cells lining the microvasculature may express both 
MHC class I and class II antigens, whereas interstitial 
dendritic cells (myocardial antigen presenting cells) express 
only MHC class II antigens (31). 
Induction of MHC antigen expression within the myocar- 
dium in patients with active myocarditis. This study supports 
previously described patterns of MHC antigen distribution in 
normal myocardium and demonstrates two abnormal pat- 
terns of induction of MHC antigens in myocardial tissue of 
patients with active myocarditis: 1) intense induction of 
MHC class I and class II antigens within the cardiac inter- 
stitium (primarily the microvasculature), and 2) abnormal 
expression of MHC class I and class II antigens on myocyte 
cell surfaces. Our preliminary findings also suggest that 
ischemic disruption of myocardial cells as occurs in ischemic 
heart disease (Group 2, Patients 14 to 18, Tables 1 and 2) 
does not induce abnormal expression of MHC class I and 
class II antigens. 
Two techniques were used to demonstrate myocardial 
MHC antigen expression. The widely available immunoper- 
oxidase method localized the cellular distribution of MHC 
expression (Fig. 2 to 4). Because the limits of sensitivity of 
this semiquantitative technique are not known, a quantita- 
tive radioimmunoassay technique was also used to provide 
an objective measurement of MHC class I and class II 
expression within the entire endomyocardial specimen. The 
immunoperoxidase and radioimmunoassay techniques are 
significantly correlated with one another for MHC class I 
and class II expression (R = 0.911, R* = 0.830, p < 0.001 
and R = 0.825, R* = 0.681, p < 0.001, respectively). 
Therefore, the radioimmunoassay confirmed the subjective 
impressions of the immunoperoxidase method. When both 
techniques are compared for their ability to predict an active 
myocarditis biopsy, logistic regression analysis reveals that 
the most significant predictors are both derived from the 
radioimmunoassay; the radioimmunoassay MHC class I 
counts/min (p < 0.0005) and the ratio of MHC class II to 
myosin content (p = 0.008). The immunoperoxidase tech- 
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nique is ideally suited for localization of MHC staining, 
whereas the radioimmunoassay is a more sensitive tool to 
quantitate these immune markers within the myocardium. 
Pattern of myocardial MHC expression by immunoper- 
oxidase. Endomyocardial biopsy specimens from active 
myocarditis patients with high radioimmunoassay counts 
invariably revealed a strong, diffuse interstitial staining 
pattern (Fig. 3 and 4) by immunoperoxidase staining. This 
diffuse increase in MHC induction, particularly within the 
cardiac microcirculation, may serve as a diffuse tissue 
marker of immune activation. Myocyte surface staining was 
focal or multifocal but frequently had equally intense stain- 
ing characteristics as compared with that of endothelium 
(Fig. 4~). Of the 11 group I patients with myocarditis and 
abnormal expression of MHC class I and class II antigens as 
measured by radioimmunoassay, 8 had foci where definite 
myocyte surface staining was seen. The possibility that the 
sarcolemmal staining resulted from peroxidase product 
spillover from the intensely positive interstitium was consid- 
ered unlikely, because the staining pattern was always focal 
(within clusters of myocytes) and not adjacent to strongly 
stained larger venous and arterial vessels. Two samples from 
patients with active myocarditis did not stain for abnormal 
levels of either MHC class I or MHC class II antigens. These 
patients could not be clinically or histologically distinguished 
from the other patients with active myocarditis. 
Interstitial inflammatory cells were more frequently MHC 
class I positive than MHC class II positive. MHC class II 
positive plasma cells were rarely identified. In addition, 
there appeared to be no consistent change in the intensity of 
myocardial or microvascular MHC expression adjacent to 
areas of interstitial inflammation or foci of myocyte necrosis. 
Although this finding may imply that there is no necessary 
role for these antigens in the pathogenesis of necrosis, it 
must be understood that 1) foci of myocyte necrosis fre- 
quently involve no more than a few individual myocytes 
(such focal increased MHC expression could easily be 
missed unless multiple step sections are examined), and 2) 
whereas focal and multifocal collections of immune cells are 
easily identified in human myocarditis, a more subtle gener- 
alized increase in interstitial mononuclear cells may also 
play a role in producing the global increase in MHC antigen 
induction throughout the myocardium. 
Relation of myocardial MHC antigen expression and circu- 
lating heart autoantibodies. Another marker of immune acti- 
vation by cardiac antigens is serologic evidence of circulat- 
ing heart autoantibodies, which have been previously 
described in patients with cardiomyopathy and myocarditis 
(34-36) postpericardiotomy syndrome (37) rheumatic cardi- 
tis and Chagas’ disease (2,3,38,39). Normal volunteers have a 
4% prevalence of circulating heart autoantibodies (unpub- 
lished data). Group I patients with myocarditis had a 62% 
prevalence of circulating heart autoantibodies, and none of 
the eight group 11 control patients had significant titers of 
antibodies. Linear regression analysis indicated that tissue- 
bound MHC antigen expression and serum circulating heart 
autoantibodies are related. The quantity of MHC class I and 
class II antigen expression within an endomyocardial biopsy 
as measured by the radioimmunoassay method correlates well 
with the titer of circulating immunoglobulin G heart autoanti- 
bodies (r = 0.593, p = 0.006 and r = 0.708, p < 0.001, 
respectively). Seven of the eight patients with myocarditis 
and significant titers of circulating heart autoantibodies had 
abnormal myocardial MHC class II antigen expression both 
by immunoperoxidase and by radioimmunoassay. 
Clinical implications. We are aware of the limitations in 
the present study. More cases of active myocarditis need to 
be studied to determine the true prevalence of increased 
myocardial and interstitial MHC antigen expression. The 
precise cellular components expressing abnormal levels of 
MHC antigens need to be more fully characterized by 
immunoelectron micrographic techniques. There is also cur- 
rently insufficient data to comment on the relation between 
expression of MHC class I and class II antigens and the 
presence of viral genome within myocardial cells and the 
relation between a clinical response to immunosuppressive 
therapy and expression of MHC antigens. In addition, this 
study only attempted to analyze histologically or clinically 
distinct categories of disease before attempting to character- 
ize the large. yet undefined group of patients with suspected 
myocarditis with nondiagnostic endomyocardial biopsies. 
Nevertheless, there is growing controversy surrounding the 
sensitivity of the endomyocardial biopsy in identifying pa- 
tients with active myocarditis on histologic grounds alone. 
Histologic lesions that characterize most cases of active 
myocarditis are focal, whereas immune markers such as the 
MHC antigen expression demonstrated in this study appear 
to be diffusely expressed throughout the biopsy sample. 
Immune markers such as MHC antigen expression on 
myocytes and microvascular endothelium could be used as a 
more sensitive tool in identifying patients who have devel- 
oped an immune-mediated cardiomyopathy. In addition to 
issues of diagnostic sensitivity, increased MHC expression 
may be a more specific marker for immune-mediated heart 
disease than are histologic findings alone. Despite having 
inflammation and myocyte damage secondary to ischemic 
heart injury, all five of our ischemic heart disease control 
samples failed to express increased MHC antigens. Immu- 
noglobulin G deposition can also be easily demonstrated 
throughout biopsy samples in cases of active myocarditis, 
but immunoglobulin G deposition appears to be a nonspecific 
marker of cardiac injury and is frequently very intensely 
positive in ischemic heart disease control samples (40). 
Conclusions. This study demonstrates the increased ex- 
pression of both major histocompatibility complex (MHC) 
class I and class II antigens on myocytes and microvascular 
endothelium in endomyocardial biopsy specimens from pa- 
tients with active myocarditis. The finding of increased MHC 
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antigen expression within the myocardium may become a 
useful adjunct to the histologic diagnosis of myocarditis. 
21. Ballardini G, Mirakian R, Bianchi FB, Pisi E, Doniach D, Bottazzo GF. 
Aberrant expression of HLA-DR antigens on bile duct epithelium in 
primary biliary cirrhosis: relevance to pathogenesis. Lancet 1984;2:1009- 
13. 
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